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abstract
 
The human and shark Na-K-Cl cotransporters (NKCCs) are 74% identical in amino acid sequence
yet they display marked differences in apparent affinities for the ions and bumetanide. In this study, we have used
chimeras and point mutations to determine which transmembrane domains (tmÕs) are responsible for the differ-
ences in ion transport and in inhibitor binding kinetics. When expressed in HEK-293 cells, all the mutants carry
out bumetanide-sensitive 
 
86
 
Rb influx. The kinetic behavior of these constructs demonstrates that the first seven
tmÕs contain all of the residues conferring affinity differences. In conjunction with our previous finding that tm 2
plays an important role in cation transport, the present observations implicate the fourth and seventh tm helices
in anion transport. Thus, it appears that tmÕs 2, 4, and 7 contain the essential affinity-modifying residues account-
ing for the humanÐshark differences with regard to cation and anion transport. Point mutations have narrowed
the list of candidates to 13 residues within the three tmÕs. The affinity for bumetanide was found to be affected by
residues in the same tm 2Ð7 region, and also by residues in tmÕs 11 and 12. Unlike for the ions, changes in bumet-
anide affinity were nonlinear and difficult to interpret: the 
 
K
 
i(bumetanide)
 
 of a number of the constructs was outside
the range of sNKCC1 and hNKCC1 
 
K
 
i
 
s.
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introduction
 
The Na-K-Cl cotransporter (NKCC; also called BSC)
 
1
 
 is
an integral membrane protein that facilitates the pas-
sage of the ions Na, K, and Cl across cell membranes.
The transporter has been identified in a wide variety of
cell types from vertebrate as well as invertebrate species
(Xu et al., 1994; Delpire et al., 1994; Payne et al., 1995;
Payne and Forbush, 1994). NKCC belongs to the cat-
ion-chloride cotransporters (CCC; Haas, 1989; Gillen
et al., 1996), a family that also includes the Na-Cl
cotransporter (NCC or TSC; Gamba et al., 1993) and
the K-Cl cotransporter (KCC; Gillen et al., 1996; Payne
et al., 1996). Two types of Na-K-Cl cotransporters have
been identified. NKCC1 is a widely distributed isoform
(Xu et al., 1994); it is found in nonpolarized cells
where it plays an important role in cell volume regula-
tion (Haas, 1989), and it is also prominent in certain
secretory epithelia where it drives net transport of fluid
and electrolytes (Xu et al., 1994). NKCC2 is a kidney-
specific isoform that occurs as three splice variants
called A, B, and F; these variants are distributed along
the thick ascending limb of Henle and play an impor-
tant role in electrolyte absorption (Payne and Forbush,
1994; Igarashi et al., 1995). 
All NKCCs described to date are characterized by a
strict dependence of transport on the three ions, Na, K,
and Cl (Forbush and Palfrey, 1983; Lytle et al., 1992;
Moore et al., 1995). In most tissues, the binding stoichi-
ometry is 1Na:1K:2Cl per transporter and, therefore,
the transport process is not associated with net movement
of charge (Haas, 1989). Loop diuretics such as furo-
semide, bumetanide, and benzmetanide inhibit cotrans-
porter function by interacting with the protein at an ex-
tracellular site (Forbush and Palfrey, 1983; Payne and
Forbush, 1995; Isenring and Forbush, 1997). This pro-
cess also requires the presence of the ions Na, K, and Cl
in the binding media. Inhibition of transport activity by
bumetanide occurs with a stoichiometry of one inhibi-
tor molecule per transporter protein (Forbush and Pal-
frey, 1983).
Members of the Na-K-Cl cotransporter family exhibit
similar hydropathy profiles, delineating three broad re-
gions: large NH
 
2 
 
and COOH termini, and a 500-residue
central domain that is predicted to contain 12 trans-
membrane domains (tmÕs). Sites of regulatory phos-
phorylation have been identified in the NH
 
2 
 
and
COOH termini, demonstrating that part of these do-
mains are intracellular. The central domain of the CCC
proteins exhibits the highest sequence conservation.
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For example, the NH
 
2
 
 terminus, the COOH terminus,
and the tmÕs of the shark and human cotransporters
are 55, 90, and 85% identical, respectively.
Despite a high level of amino acid sequence conser-
vation in the NKCC1, apparent affinities for the ions
and for bumetanide vary as functions of the species
(Payne and Forbush, 1995; Isenring and Forbush, 1997;
Isenring et al., 1998
 
b
 
). For example, the 
 
K
 
m
 
 for all the
ions and the 
 
K
 
i(bumetanide)
 
 are four- to sixfold lower in the
human cotransporter compared with the shark protein.
In previous studies, we took advantage of these differ-
ences to identify regions that are responsible for medi-
ating transport and binding characteristics in the two
species. By interchanging the NH
 
2
 
 and COOH termini
between the shark and human carriers, we were able to
demonstrate that the large hydrophobic central do-
main encodes all of the information involved in specify-
ing the kinetic singularities of the wild-type proteins
(Isenring and Forbush, 1997). Further experiments
showed that the second tm plays an important role in
the species differences in both cation and bumetanide
affinities (Isenring et al., 1998
 
a
 
). Interestingly, this do-
main is not involved in determining Cl affinity, suggest-
ing that residues beyond
 
 
 
tm 3 encode cotransporter be-
havior for anion transport.
In this study, we have pursued the chimera approach
and examined the role of tmÕs 4Ð12. We find that vari-
ant residues between tmÕs 4 and 7 also account for hu-
manÐshark differences in ion transport. Further analy-
sis using site-specific mutagenesis confirms the results
obtained with the chimeras, and in conjunction with
the results described above, shows that tmÕs 2, 4, and 7
contain the essential residues that determine the ki-
netic behavior of the NKCC1s. On the other hand, we
find that bumetanide binding involves multiple resi-
dues localized before as well as beyond tm 7. 
 
methods
 
Nomenclature for cDNA Constructs
 
As previously described (Isenring and Forbush, 1997), we use sin-
gle letters in lowercase to designate domains from an NKCC spe-
cies (h,
 
 
 
human; s,
 
 
 
shark) that are included in a chimera. A num-
ber 1.xÐ12.x refers to the position of the chimeric junctions in
the 12 putative tmÕs, and a number 1L.xÐ11L.x refers to the con-
necting loops after each tm 
 
a
 
 helix. Each domain is further di-
vided into 10 subdomains from x.0 to x.9. The application of this
nomenclature is illustrated in Fig. 1, which presents models of
the NKCC1 constructs used in these studies.
All the point mutations described here are in the sNKCC1 se-
quence and consist of sNKCC1 
 
® 
 
hNKCC1 replacements. A num-
ber in parenthesis indicates the site of the mutations following
the nomenclature described above. In 
 
GD-VL
 
(5.3)
 
 for example, the
 
GD
 
 and 
 
VL
 
 residues from hNKCC1 replace the corresponding 
 
VN
 
and 
 
TV
 
 residues in the sNKCC1 sequence; the substitutions are
located near the middle of tm 5 (site 5.3). These point mutations
are shown in Fig. 1.
 
Vectors
 
A mutant p-Bluescript (pBS
 
M
 
-SK
 
2
 
) containing additional restric-
tion sites in the polylinker (Isenring and Forbush, 1997) was used
to facilitate various subcloning steps. The wild-type sNKCC1 was
subcloned in the vector pTZ18U (Bio-Rad Laboratories, Rich-
mond, CA) at XbaI-KpnI sites to serve as a template for site-directed
mutagenesis. The vector used for expression of wild-type and mu-
tant cDNA (pJB20
 
M
 
) was as in Isenring and Forbush (1997). The
vector pJB20 is derived from pCB6 and contains additional in-
tronic sequences in the 3
 
9
 
 linker to improve transcript stability.
The vector also contains the strong cytomegalovirus promoter
and a G418 resistance cassette for selection of transfectants. In
pJB20
 
M
 
, additional restriction sites were also introduced in the
polylinker to facilitate subcloning.
 
Chimeras and Mutations
 
The chimeras hsh5L.7/13.1 and shs5L.7/13.1 (shown in Fig. 1, 
 
A
 
and 
 
B
 
, respectively) were generated by fragment exchange at the
restriction site ApaI situated at bp 1596 of hNKCC1. This site oc-
curs at three other locations in the hNKCC1 cDNA (bp 341, 381,
Figure 1. Models for sNKCC1,
hNKCC1, five chimeras, and
three point mutations in tmÕs of
sNKCC1 based on proposed
structure (Payne et al., 1995).
Circles symbolize amino acid res-
idues (gray,  human NKCC1;
black, sNKCC1). AI-V-I-L(4.5) is a
tm-4 sNKCC1 mutant with the
substitutions S386, V387, I389, V391,
and F393 ® A414, 415, V417, I419, and
L421. In the mutant GD-VL(5.3),
V419, N420, T422, and V423 in tm 5
of sNKCC1 are replaced by the
corresponding G447, D448, V450,
and L451 of hNKCC1. In the
shark  L-V-I-A(7.7) mutant, the sub-
stitutions are I504, A507, A509, and
V511 ® L532, V535, I537, and A539 in
the tm 7 of the sNKCC1 protein. 
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and 660), but is absent in sNKCC1. We used the Kunkel method to
introduce an ApaI site (sNKCC1
 
APA
 
/pTZ18U) at the junction 5L.7
in the sNKCC1 cDNA (bp 1785); the mutagenic oligonucleotide,
shown in Table I (A), changes the valine at position 450 in
sNKCC1 to a glycine in the extracellular loop. The junction corre-
sponds to residues V
 
450
 
 
 
® 
 
G/P
 
451
 
 in sNKCC1 and G
 
478
 
/P
 
479
 
 in
hNKCC1. The other junction site at 13.1 corresponds to residues
H
 
756
 
/V
 
757 
 
in sNKCC1 and H
 
783
 
/V
 
784
 
 in hNKCC1. After creating the
ApaI site in sNKCC1, hsh5L.7/13.1 was generated in two separate
steps. First, the Bst1107I-ApaI fragment of sNKCC1
 
APA
 
/pTZ18U
(600 bp) was ligated to the Bst1107I-ApaI fragment of hNKCC1/
pJB20
 
M
 
 (9,600 bp) to generate shs0.9/5L.7 in pTZ18U. In the sec-
ond step, the following fragments were ligated: KpnI-Bst1107I
from hNKCC1/pJB20
 
M
 
 (1,100 bp), Bst1107I-PmlI from shs0.9/
5L.7 in pTZ18U (1,500 bp), and PmlI-KpnI from hNKCC1/
pJB20
 
M
 
 (7,800 bp). The chimera shs5L.7/13.1 was generated in a
single step ligation using the following fragments: KpnI-ApaI from
sNKCC1
 
APA
 
/pTZ18U (1,800 bp), ApaI-PmlI from hNKCC1/
pJB20
 
M
 
 (900 bp), and PmlI-KpnI from sNKCC1/pJB20
 
M 
 
(8,800
bp). Representations of the chimeras are shown in Fig. 1, 
 
A
 
 and 
 
B
 
.
For the chimeras hsh7.9/13.1 and shs7.4/13.1 (shown in Fig. 1,
 
C
 
 and 
 
D
 
, respectively), the junction points are in tm 7 (Y
 
506
 
/A
 
507
 
 
 
®
 
V
 
 
 
in sNKCC1 and Y
 
534
 
/V
 
535
 
 in hNKCC1) and at 13.1 (as described
above). For the tm 7 junction, a SnaBI restriction site is present in
hNKCC1 (bp 1761) but absent in the shark sequence. We used the
Kunkel method to obtain a matching site in sNKCC1 at bp 1950.
The SnaBI-containing oligonucleotide, shown in Table I (B), also
introduces four substitutions in sNKCC1; the residues I
 
504
 
, A
 
507
 
,
A
 
509
 
, and V
 
511 
 
are replaced by their counterparts L
 
532
 
, V
 
535
 
, I
 
537
 
, and
A
 
539
 
 from hNKCC1. The resulting mutant, 
 
L-V-I-A
 
(7.7)
 
/pTZ18U or
sNKCC1
 
SNAB
 
/pTZ18U, was used to generate hsh7.9/13.1 and
shs7.4/13.1. The KpnI-SnaBI fragments of hNKCC1/pBS
 
M
 
-SK
 
2
 
(1,800 and 5,300 bp; see Isenring and Forbush, 1997) and of
sNKCC1
 
SNAB
 
 /pTZ18U (2,000 and 6,200 bp) were cross-ligated to
generate hs7.9/pTZ18U and sh7.4/pBS
 
M
 
-SK
 
2
 
; the KpnI-PmlI frag-
ment of each mutant (2,500 and 2,700 bp) was religated to the
KpnI-PmlI fragment of hNKCC1/pJB20
 
M
 
 or sNKCC1/pJB20
 
M
 
 to
generate hsh7.9/13.1 and shs7.4/13.1. As illustrated in Fig. 1, 
 
C
 
and 
 
D
 
, these two chimeras are not perfect complements of one an-
other since they share human residues in tm 7.
The chimera hsh10.5/13.1 (see Fig. 1 
 
E
 
) was produced by ex-
changing human/shark fragments at NdeI and PmlI restriction
sites after creating a NdeI site in sNKCC1 at bp 2410 (sNKCC1
 
NDE
 
/
pTZ18U) to match the human site at bp 2218 [see oligonucleotide
in Table I (C)]. The junction point 10.5 corresponds to Y
 
686
 
/A
 
687
 
in hNKCC1 and to Y
 
659
 
/A
 
660 
 
in sNKCC1. Chimeras hs3.1 and sh3.1
were available from the studies in Isenring et al., 1998
 
a
 
.
The point mutations 
 
AI-V-I-L
 
(4.5)
 
, 
 
GD-VL
 
(5.3)
 
, and 
 
L-V-I-A(7.7),
shown in Fig. 1, FÐH, were created with the Kunkel method using
mutagenic oligonucleotides [see Table I (DÐF)]. Residues in
sNKCC1 were replaced with corresponding residues from
hNKCC1:  AI-V-I-L(4.5) was generated by replacing the S386, V387,
I389, V391, and F393 residues in the tm 4 sNKCC1 sequence by the
A414, I415, V417, I419, and L421 residue counterparts from hNKCC1;
for GD-VL(5.3), V419, N420, T422, and V423 in tm 5 were replaced by
G447, D448, V450, and L451; for L-V-I-A(7.7), I504, A507, A509, and V511 in
tm 7 were replaced by L532, V535, I537, and A539.
Silent restriction sites or residue substitutions were confirmed
by partial automated sequencing (W.M. Keck Foundation Bio-
technology Resource Lab DNA Sequencing Group, Yale Univer-
sity) and/or by extensive restriction analyses.
Cell Lines
Lines stably expressing hNKCC1and sNKCC1 were the same as in
Isenring and Forbush, 1997. The five chimeras and three point
mutations were transfected into HEK-293 cells by calcium phos-
phate precipitation and stable lines (generally 12Ð16) were iso-
lated by G-418 resistance after screening with 86Rb influx assays,
Western blotting, or immunofluorescence. Transfected HEK-293
cells were maintained in DulbeccoÕs modified EagleÕs medium
supplemented with 10% fetal bovine serum (Life Technologies,
Inc., Grand Island, NY), penicillin, streptomycin, and G-418 (950
mg/ml). The level of functional expression achieved with six of
eight constructs was comparable to the wild-type hNKCC1 and
sNKCC1 (Isenring and Forbush, 1997), approximately six- to
eightfold above the endogenous cotransport activity of mock-
transfected HEK-293 cells (results not shown). The chimeras
shs5L.7/13.1 and shs7.4/13.1 (see Fig. 1, B and D) were found to
transport 86Rb at a lower rate, approximately threefold above the
background. When cotransporter expression was tested by immu-
nofluorescence using J3 and J7 antibodies, predominant cell sur-
face expression as well as perinuclear staining were observed
(Isenring et al. 1998a).
Protein Analysis
Experiments were performed as previously described (Lytle et al.,
1992). In brief, transfected HEK-293 cells were allowed to grow
to near confluence and solubilized in 3% CHAPS {3-[(3-chiola-
mido-propyl)dimethylammonio]-1-propanesulfonate} with pro-
tease inhibitors. Whole cell lysates were assayed for protein con-
tent by the Micro BCA method (Pierce Chemical Co., Rockford,
IL). Western blots (2Ð5-mg protein samples) were carried out us-
ing the sNKCC1 monoclonal antibodies J3 or J7 (Lytle et al.,
1992). As previously reported (Isenring and Forbush, 1997), J3
recognizes a segment of the NH2 terminus located between resi-
dues 49 and 196, and J7 recognizes a COOH terminal segment
situated between residues 1050 and 1168. As shown in Fig. 2, the
level of cotransporter synthesis and the pattern of glycosylation
were comparable for all the cell lines studied in this project. Rec-
ognition by J3 and J7 was also consistent with whether the NH2 or
COOH terminus was derived from the shark NKCC1.
Flux Studies
As previously described (Isenring and Forbush, 1997), HEK-293
cells were subcultured onto 96-well plates precoated with poly-
lysine and grown to confluence (6Ð8 d). Ion transport rates and
bumetanide binding were determined by 86Rb influx measure-
ments. All experiments were done at room temperature (.228C)
and the solutions were at pH 7.4. The cells were preincubated in
hypotonic low Cl (163 mosM, 2 mM Cl) medium for 1 h (67.5 mM
Na gluconate, 2.5 mM K gluconate, 0.5 mM CaCl2, 0.5 mM
MgCl2, 0.5 mM Na2HPO4, 0.5 mM Na2SO4, and 7.5 mM Na
HEPES) to activate cotransporter activity. For bumetanide inhibi-
tion studies, the cells were also preincubated 15 min with the in-
hibitor diluted in a 20-mM Cl solution (154 mM Na and 144 mM
Cl). The influxes were performed for 1 min in a medium con-
taining 135 mM NaCl, 5 mM RbCl (2 mCi/ml  86RbCl), 1 mM
CaCl2, 1 mM MgCl2, 1 mM Na2HPO4, 1 mM Na2SO4, 15 mM Na
table i
Oligonucleotides Used to Generate the Five Point Mutations
in sNKCC1 or hNKCC1
A sNKCC1APA ct gaa aac ttt ggg ccc gat ttt cgt gat g
B sNKCC1SNAB ca att gtc tac gta gga ata gct gct tct gta gtt tc
C sNKCC1NDE c ctg gct tca tat gct ttg att ttc
D AI-V-I-L(4.5) att ata gga gcc att act gtc gtg atc ctg ctt ggc ata tc
E GD-VL(5.3) cta tta gct ata ggt gac ttc gtc ata gga act ttc atc cca g
F L-I-V-A(7.5) same as B552 Ion Transport by the Na-K-Cl Cotransporter
HEPES, and 0.1 mM ouabain; when necessary, Na and Rb were
replaced with equimolar amounts of N-methyl glucamine, and Cl
was replaced with gluconate. To determine bumetanide-sensitive
influx, 250 mM bumetanide was added directly to the media. 86Rb
uptake was terminated by addition of, and three rinses in, ice-
cold stop solution (135 mM K gluconate, 5 mM Na gluconate, 1 mM
CaCl2, 1 mM MgCl2, 1 mM Na2HPO4, 1 mM Na2SO4, 15 mM Na
HEPES, 250 mM bumetanide, and 0.1 mM ouabain). Cells were
solubilized in 2% sodium dodecylsulfate, and assayed for protein
content and for 86Rb by counting Cerenkov radiation.
Each concentration curve was carried out in a single row of the
96-well plate, and in a typical experiment there were two to six
replicate rows. Data were handled on a per-row basis and counts
were normalized to the value at the highest ion concentration, or
to the value of uninhibited flux in inhibition studies. Km and Ki
values were obtained by nonlinear least-squares curve fitting us-
ing the Simplex algorithm (program PLOT, B. Forbush), and are
expressed as means 6 SEM among all rows in 4Ð15 experiments.
Rows with obvious rogue values (data sets for which least squares
fits did not converge, or for which individual data points were
.2.0 or ,0.5 of the value of the fit line) were omitted from aver-
ages, in all cases less than one row in eight. 
Chemicals and Reagents
Where not otherwise noted, general chemicals and reagents were
from Sigma Chemical Co. (St. Louis, MO), and reagents for mo-
lecular biology and tissue culture were from New England Bio-
labs, Inc. (Beverly, MA), FMC Bioproducts (Rockland, ME), and
GIBCO BRL (Gaithersburg, MD).
Calculation of Kinetic Parameters for the Ordered 
Binding Model 
Predictions of kinetic parameters of the ordered binding model
of Miyamoto et al. (1986) and Lytle et al. (1998) were obtained
by solving the set of simultaneous rate equations describing the
transport model (see Benjamin and Johnson, 1997). Isotopic ex-
change was included by explicitly considering labeled and unla-
beled Rb as independently transported species. Solutions were
obtained at various concentrations of a test ion, and Kms were ob-
tained from fits of these curves (for Cl, a fixed Hill coefficient, n 5
2, was used for parallelism to our treatment of data; actually, best
fits are obtained with Hill 7 . 1,6; as discussed in a footnote in
Isenring and Forbush, 1997). For simplicity, the constants are
symmetrical across the membrane; constants were chosen to pro-
duce Kms near those of hNKCC1. All association rate constants
were 107 s21 M21, translocation rate constants for unloaded and
loaded carrier were 40,000 and 10,000 s21, respectively, and affin-
ities (1/Kd) for Na, Rb, and Cl (at each of two sites) were 127, 54,
and 6 mM, respectively (program PLOT, B. Forbush).
results
Role of tmÕs 10Ð12 in Ion Transport Compared with That of 
tmÕs 1Ð9 
To determine if the last two tmÕs of NKCC1 contain af-
finity-specifying residues, we replaced these segments
by the corresponding shark sequence (hsh10.5/13.1;
see Fig. 1 E). Between the species, these last two tmÕs
differ by six residues, while predicted a helix 10 is fully
conserved. The dependence of 86Rb influx on [Na],
[Rb], and [Cl] is illustrated in Fig. 3. The data demon-
strate that shark residues in tmÕs 11 and 12 have no ef-
fect on the kinetic behavior of hNKCC1. The Km(Na),
Km(Rb), and Km(Cl) are 14, 1.9, and 34 mM, similar to
those reported for the hNKCC1-transfected cells (15,
1.7, and 31 mM, respectively). 
Figure 2. Western blot analyses of cDNA-transfected HEK-293
cells using the shark NKCC1 monoclonal antibodies J3 (top) and J7
(bottom).
Figure 3. Dependence of 86Rb
influx on [Na], [Rb], and [Cl] for
the chimera hsh10.5/13.1. The
data are shown as averages of 30Ð
40 flux rows in 7Ð10 experi-
ments.553 Isenring et al.
Role of tmÕs 7Ð9 Compared with That of tmÕs 1Ð6
To next determine the contribution of domains 7Ð9 in
ion transport by the Na-K-Cl protein, we examined two
other humanÐshark chimeras with a junction located in
tm 7 (hsh7.9/13.1 and the nearly complementary shs7.4/
13.1; see Fig. 1, C and D). The Km values derived from
the dependence of 86Rb transport on [Na], [Rb], and
[Cl] are summarized in Fig. 4. They show that the
hsh7.9/13.1 chimera has a phenotype that is indistin-
guishable from hNKCC1; the Km(Na), Km(Rb), and Km(Cl)
are 19, 1.8, and 31 mM, respectively. Thus, it appears
that tmÕs 8 and 9, as shown above for tmÕs 10Ð12, do
not confer differences in ion affinities between human
and shark. These results, in conjunction with previous
observations that the NH2 and COOH termini are de-
void of affinity-modifying properties (Isenring and For-
bush, 1997), indicate that differences in apparent bind-
ing parameters between the two cotransporters are
specified by residues found in the first seven tmÕs.
Interestingly, ion constants for the nearly comple-
mentary chimera shs7.4/13.1 are all intermediate be-
tween human and shark. Since the results described
above rule out a role for tmÕs 8Ð12, tm 7 could contain
all of the variant residues accounting for the behavior
of shs7.4/13.1. To test this hypothesis, we characterized
the ion dependence of 86Rb influx in L-V-I-A(7.7)-trans-
fected cells. In this sNKCC1 mutant (see Fig. 1 H), all
the tm-7 residues were replaced by their human residue
counterparts. It is seen in Fig. 4 that the ion constants
for L-V-I-A(7.7) are very similar to those of shs7.4/13.1.
This result confirms that the behavior of shs7.4/13.1,
relative to that of sNKCC1, was mediated through sub-
stituted residues in tm 7. The data is also consistent
with previous observations in showing that residues in
tmÕs 8Ð12 do not encode variant transport behaviors.
Role of tmÕs 4Ð5 
Of tmÕs 1 to 6, only 2 and 4 or 5 could potentially medi-
ate differences in ion affinities between the human and
shark cotransporters; as shown in Fig. 7 A, tmÕs 1, 3,
and 6 are fully conserved. We have previously deter-
mined that tm 2 plays a role in cation transport, but is
not involved in Cl affinity differences (Isenring et al.,
1998a). Specifically, the chimera hs3.1 had cation affin-
ities that were intermediate between sNKCC1 and
hNKCC1, and a Cl affinity that was similar to that of
sNKCC1 (results from Isenring et al. [1998a] are repro-
duced in Fig. 5). Thus, with regard to cations, tmÕs 2
and 7 could contain all of the information that defines
the kinetic behavior of NKCC1: each domain endows
approximately half the affinity difference between the
species. For the anions, on the other hand, tmÕs 4 or 5
are likely to play an important role given that variant
residues in tm 7, as shown above with L-V-I-A(7.7), ac-
count for only part of the differences in Km(Cl) between
sNKCC1 and hNKCC1.
To test these predictions, we analyzed the role of tmÕs
4 and 5 in Na transport by using two additional chime-
ras (hsh5L.7/13.1 and shs5L.7/13.1) with a junction
point situated in the connecting loop after the fifth tm
helix (see NKCC1 in Fig. 1, A and B). The dependence
of  86Rb influx on [Na] translates into similar Kms for
both chimeras, as depicted in Fig. 5 A, and these con-
stant values are not significantly different from the
Km(Na) previously reported for hs3.1. The results con-
firm that the differences in Na affinity between shark
and human are not specified by residues located in
tmÕs 4 and 5.
Unexpectedly, analysis of the same chimeras demon-
strates that tmÕs 4 or 5 are possibly involved in the Rb
affinity difference. The data in Fig. 5 B show that when
tmÕs 2, 4, and 5 are from hNKCC1, and 7 is from
sNKCC1 (chimera hsh5L.7/13.1; see Fig. 1 A), the
Km(Rb) is intermediate between human and shark, and
lower than the constants obtained for L-V-I-A(7.7) and
hs3.1. In conjunction with our previous observations,
these results indicate that three tmÕs (2, 4 or 5, and 7)
may be involved in determining Rb affinity. The behav-
ior of the complementary chimera shs5L.7/13.1 (see
Fig. 1 B) is consistent with expectation in showing a Rb
affinity that is intermediate between human and shark
Figure 4. Km(Na),  Km(Rb), and Km(Cl) for the
hsh7.9/13.1 and the shs7.4/13.1 chimeras, and for
the sNKCC1 point mutant L-V-I-A compared with
the wild-type proteins (as described above, the resi-
due replacements in L-V-I-A(7.7) are I504, A507, A509,
and V511 ® L532, V535, I537, and A539). The values for
sNKCC1 and hNKCC1 are from Isenring et al.
(1998). For the other constructs, the data are
shown as averages of 10Ð40 flux rows in 4Ð15 ex-
periments for Na, 25Ð34 flux rows in 8Ð14 experi-
ments for Rb, and 16Ð37 flux rows in 4Ð7 experi-
ments for Cl. 554 Ion Transport by the Na-K-Cl Cotransporter
(Fig. 5 B), and close to that of L-V-I-A(7.7) (6.3 mM com-
pared with 4.8 mM). This result confirms the role of tm
7 as a Rb affinity-modifying domain, and is concordant
with the fact that tm 6 is fully conserved between hu-
man and shark.
The kinetic behavior of the 5L.7/13.1 chimeras with
regard to the Cl dependence of 86Rb influx is summa-
rized in Fig. 5 C. It is seen that the Km(Cl) for hsh5L.7/
13.1 is intermediate between human and shark (54 mM,
compared with 31 and 107 mM for hNKCC1 and
sNKCC1, respectively), and that it is similar to the value
obtained for L-V-I-A(7.7). The Km(Cl) for the reverse chi-
mera shs5L.7/13.1 is also similar to that of L-V-I-A(7.7)-
transfected cells. These results confirm our hypothesis
above that tmÕs 4 or 5, along with tm 7, must account
for differences in anion affinity between the human
and shark carriers.
To further determine which of tmÕs 4 and 5 mediated
affinity behaviors with regard to Rb and Cl, we analyzed
the point mutation GD-VL(5.3) (see Fig. 1 G), in which
residues in the tm 5 shark sequence (n 5 4) were sub-
stituted by corresponding residues from hNKCC1 (a
similar tm 4 shark mutant, AI-V-I-L(4.5), was nonfunc-
tional; see Fig. 1 F). The ion dependence of 86Rb influx
for GD-VL(5.3)-transfected HEK cells (Fig. 5) yields con-
stants for Na, Rb, and Cl that are very similar to
sNKCC1: 91, 11, and 108 mM, compared with 109, 12,
and 107 mM for the wild-type sNKCC1. This finding sug-
gests that tm 5 does not contain affinity-modifying resi-
dues; hence, some residues in tm 4 must account for
the higher Rb-Cl affinity obtained for hsh5L.7/13.1
compared with hs3.1.
Regions Involved in Bumetanide Binding
sNKCC1 has an apparent affinity for bumetanide that
is three- to fourfold lower than that of hNKCC1 (Payne
et al., 1995; Isenring and Forbush, 1997). Our previous
studies have demonstrated that these differences are
encoded by the 500-residue central domain of the pro-
tein (Isenring and Forbush, 1997), and that residues in
or near the second tm appear to be responsible for part
of the effect. To extend this analysis, we measured bu-
metanide inhibition of 86Rb influx in the five chimeras
discussed above, as summarized in Fig. 6.
Looking first at the results with hsh7.9/13.1 (see Fig.
1 C), we observe that the bumetanide affinity of this
chimera is 1.5-fold lower than that of the parent
hNKCC1. This indicates that, unlike the situation for
ions, residues beyond the seventh tm do have an effect
on bumetanide binding. This fact is also illustrated by
the behavior of chimera hsh10.5/13.1, which is 2.5-fold
more sensitive to bumetanide than is hNKCC1; this
shows that residues in tm 11 or 12 affect bumetanide
binding.
Surprisingly, the bumetanide-binding behavior illus-
trated in Fig. 6 does not fit the principle of additivity
that seems to apply to the ion transport properties of
the chimeras. For instance, three chimeras exhibit bu-
metanide affinities that are even higher than that of
hNKCC1, and one chimera (hsh5L.7/13.1; Fig. 1 A) ex-
hibits an affinity that is even lower than that of
Figure 6. Bumetanide inhibition constants for the five chimeras
compared with those of sNKCC1 and hNKCC1. Ki(bu) for the wild-
type proteins are from Isenring et al. (1998).
Figure 5. Km(Na), Km(Rb), and Km(Cl) for the 5L.7/
13.1 chimeras and the sNKCC1 point mutant GD-
VL compared with hs3.1 (see Isenring et al., 1998)
and the wild-type proteins (as described above,
the residue replacements in GD-VL(5.3) are V419,
N420, T422 and V423 ® G447, D448, V450, and L451 of
hNKCC1). The values for hs3.1, sNKCC1, and
hNKCC1 are also from Isenring et al. (1998). For
the other constructs, the data are shown as aver-
ages of 24Ð43 flux rows in 6Ð11 experiments for
Na, 29Ð48 flux rows in 7Ð10 experiments for Rb,
and 13Ð35 flux rows in 3Ð7 experiments for Cl.555 Isenring et al.
sNKCC1. Although, interestingly, the 5L.7/13.1 chime-
ras exhibit reciprocal forms of this Òmisbehavior,Ó we
have been unable to develop a simple model to explain
the data. One possibility is that conformational interac-
tions between extracellular domains affect the struc-
ture of the bumetanide binding site.
discussion
In this study, we have identified regions in NKCC1 that
confer the differences between shark and human NKCC1
in the kinetics of ion transport. By studying chimeric
constructs of shark and human cotransporters, we have
been able to demonstrate that these differences are
caused by variant residues found exclusively in a region
that includes the first seven tmÕs (see Fig. 7 A). Using
site-directed mutagenesis, we further determined that
the residues involved are localized in the predicted tm
a helices, but not in the predicted intracellular or ex-
tracellular loops. In the current work, we have identi-
fied tmÕs 4 and 7 as determining part of the differences
in Kms: in conjunction with our previous findings (Isen-
ring and Forbush, 1997; Isenring et al., 1998a), the
data demonstrate that residues in tmÕs 2, 4, and 7 con-
tain all of the information specifying sharkÐhuman ki-
netic differences in ion transport.
A summary of the mutagenic mapping studies is
shown in Fig. 7 B. Plotted are approximate percent
changes in apparent affinity contributed by each tm, in-
ferred from differences in Km values resulting from sub-
stitution of residues in the shark sequence. The current
studies show that changes in tm 7 affect the Km for all
three ions, and that changes in tm 4 impact mainly Rb
and Cl affinities. On the other hand, tm 2 residues se-
lectively affect Kms for cations. Two residues have been
implicated in determination of Na affinity, and two
other residues in the determination of Rb affinity. To a
first approximation, the affinity changes that occur in
the three individual tmÕs are additive in accounting for
the full difference between shark and human cotrans-
porter kinetics.
We have used site-specific mutagenesis to localize
pairs or groups of residues that account for humanÐ
shark differences in ion affinities. We have narrowed
the search to 13 candidate residues in three tmÕs, and it
is possible that as few as four of these are important:
two in tm 2 and one each in tmÕs 4 and 7. These resi-
dues may be within the translocation pocket, interact-
ing directly with transported ions. A helical-wheel dia-
gram of the three tmÕs is shown in Fig. 7 C, highlighting
the candidate residues in boxes. Each helix is oriented
with the most hydrophilic side towards the hypothetical
pore, and it is seen that in each of the tmÕs, at least one
to two of the candidate residues are on this face.
Interestingly, in predicted tmÕs 2, 4, and 7, there is
Figure 7. (A) Identity plot between the human and shark
cotransporters. Here, residues that are identical between the spe-
cies are represented by gray symbols, and residues that are unique
to the shark cotransporter are represented by black symbols. (B)
Fractional change in affinity relative to sNKCC1 as contributed by
each tm (see text). (C) Helical wheels of tmÕs 2, 4, and 7. Using an
angle of 1008, wheels are drawn so the most hydrophilic poles face
each other. Hydrophilic amino acids are represented by solid let-
ters, and hydrophobic residues by open letters. Boxed letters indi-
cate candidate affinity-modifying residues as determined by muta-
tional analyses.556 Ion Transport by the Na-K-Cl Cotransporter
only one charged residue, an arginine at the extracellu-
lar end of tm 4. In the Na-K-Cl transporter in which
both anions and cations are proposed to pass single file
through a translocation pocket (Lytle et al., 1998), it
might be expected that charged groups would pose sig-
nificant barriers to ion entry into or exit from the
pocket. An alternative possibility is that a significant
amount of ion coordination is through oxygen atoms
in serine and threonine side chains as well as in the
peptide backbone (Kaplan et al., 1994; Doyle et al.,
1998). Serine and threonine side chains have been im-
plicated in several ion binding sites both indirectly (Ar-
guello and Lingrel, 1995) and through crystallographic
analysis (Toney et al., 1995). Interestingly, the ser/thr
composition of tmÕs 2 and 8 of NKCC is remarkably
high, particularly near the intracellular end of the pre-
dicted helices, suggesting a role in ion coordination
(the number of threonine residues in tm 2 is even
higher if the helix is one turn longer at the cytoplasmic
end).
As we have previously discussed (Isenring and For-
bush, 1997; Isenring et al., 1998a), regions that confer
species differences in the kinetics of ion translocation
are possibly not the same residues that are essential for
ion binding. Some of the essential residues must be
fully conserved through evolution and these would not
be identified by a technique aimed at correlating func-
tional differences with structural differences. Nonethe-
less, in the example recently provided by the structure
of a K channel (Doyle et al., 1998), residues that affect
K selectivity have been shown to be those that are di-
rectly involved in ion coordination. This supports our
hypothesis that the identified NKCC1 residues are
closely involved with the ion binding sites and that some
of them may indeed directly participate in ion binding.
The measurable kinetic behavior of an ion trans-
porter is determined by a number of kinetic constants,
including all of the rate constants for the various steps
in the transport cycle. In the case of a multi-ion cotrans-
porter such as NKCC, this is a particularly complex sys-
tem in which a change in affinity for one ion may
change the Km (Òapparent affinityÓ) for other ions. For-
tunately, the way in which these constants are interre-
lated has been determined experimentally for NKCC1
(Miyamoto et al., 1986; also Isenring, P., S.C. Jacoby,
and B. Forbush, unpublished data, for sNKCC1 and
hNKCC1). These data, as well as transport data for vari-
ous cis and trans ions (Lytle et al., 1998), support an or-
dered binding model for Na-K-Cl transport in which ex-
tracellular ions bind in the order Na1-Cl2-K1-Cl2 and
are released in the same order on the inside of the
membrane (Miyamoto et al., 1986; Lytle et al., 1998).
For the present work, we are able to infer the signifi-
cance of Km changes based directly on the available ki-
netic data and from predictions of the ordered model.
Such relationships are illustrated in Fig. 8 by kinetic
predictions for a particular set of model parameters
(this is only an example: the quantitative behavior de-
pends on the specific choice of parameters, and there
is currently too little information to determine these
uniquely). The interdependence of kinetic constants is
illustrated by the fact that every Km changes in response
Figure 8. Kinetic parameters
of  86Rb influx through the Na-K-
Cl cotransporter based on the or-
dered binding model of Lytle et
al. (1998) and Miyamoto et al.
(1986). Plotted are predicted val-
ues of observed 1/Km for Na
(left), Rb (center), or Cl (right) as a
function of change of Na or Rb
affinities (top), of Cl affinities at
two sites (center), or of the rate
constants for translocation of
loaded or unloaded carriers (bot-
tom). Values of the model param-
eters are given in methods; pre-
dicted Km values are relative to
14.2, 1.5, and 32 mM for Na, Rb,
and 2Cl, respectively.557 Isenring et al.
to a change in binding site affinity for any of the ions.
However, as a general rule, the apparent affinity of one
ion in the ordered binding scheme is most affected by
changes in the true affinities of ions that bind subse-
quently, particularly by the affinity of the ion immedi-
ately following.
With regard to the effect of variant residues in tm 2,
Km(Na) is affected by changes in one pair of residues and
Km(Rb) by another pair; there is, however, a smaller
change in Km(Cl) (Isenring et al., 1998a). These results
are probably attributable to changes in the real affinity
for Na and Rb at the two sites, since no other change in
kinetic constants would result in this behavior in the or-
dered binding model. This interpretation is consistent
with the expectation of the model that, at high Na and
Rb concentrations, changes in either Na or Rb affinity
have smaller effects on Kms for the other ions; they are
also consistent with the experimental observations of
Miyamoto et al. (1988) and with our own observations
(Jacoby, S.C., P. Isenring, and B. Forbush, unpublished
data) that changes in [Na]ext or [K]ext have sublinear ef-
fects on Km(Na) and Km(K), respectively.
The kinetic changes associated with tm 4 substitu-
tions affect Km(Rb) and Km(Cl), but not Km(Na). This behav-
ior is most consistent with a tm 4Ðrelated change in the
true affinity for Cl at the second of two Cl binding sites
(see Fig. 8, middle row, s). Differences in tm 7 affect the
affinity for all three ions: this result could reflect a
change in true affinity at the first Cl binding site, but it
could also be explained by a change in multiple kinetic
parameters or in the rate constant for movement of the
loaded carrier (Fig. 8, bottom).
This work has also offered considerable insight into
the regions of NKCC involved in loop-diuretic binding.
(a) Expanding on our earlier report (Isenring et al.,
1998a), we find that the pattern of changes that affect
bumetanide binding is not the same as the pattern of
those changes affecting kinetics of ion translocation.
This finding is inconsistent with the hypothesis that the
bumetanide binding site is identical with one of the Cl
binding sites (Haas and McManus, 1983; Turner and
George, 1988), but it does not rule out the possibility
that some of the residues involved in bumetanide bind-
ing are part of the Cl translocation site. (b) In contrast
to our observation that changes in ion translocation in-
volves only the first seven tmÕs, changes in tm 11 and 12
residues are found to alter the kinetics of bumetanide
inhibition. (c) Many of the chimeras exhibit bumet-
anide affinities that are outside the range of the parent
NKCC molecules, and we have not found a simple
model that can explain the results. One possible expla-
nation is that the bumetanide binding site spans multi-
ple domains on NKCC and that conformational inter-
actions, possibly within extracellular loops, give rise to
complexities in the behavior of chimeric constructs.
In conclusion, we have found that tmÕs 2, 4, and 7
contain the residues that confer the differences be-
tween shark and human NKCC1 with regard to ion
translocation kinetics, and we propose that these heli-
ces form part of the Na-Cl-K-Cl binding pocket. Struc-
tural considerations suggest that at least four helices
would be involved in forming a translocation ÒporeÓ
(Doyle et al., 1998); other candidate helices for the Na-
K-Cl cotransporter include the S/T-rich tm 8 and the
very highly conserved tmÕs 1 and 6. Parameters affect-
ing bumetanide binding appear to be more complex,
indicating that loop-diuretic binding involves interac-
tions with multiple regions of the transporter in the
large central domain.
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